Skip to main content
. 2007 Jun 1;66(6):859–868. doi: 10.1111/j.1365-2265.2007.02825.x

Fig. 2.

Fig. 2

Individual IGF-1 levels at baseline and after 24 and 48 weeks of treatment with octreotide LAR. Shaded areas represent the normal, age-adjusted range.